The Latest Breaking News from Stryker

Stryker has underperformed the broader market this year, but Wall Street analysts are moderately bullish about the stock’s prospects.

Stryker narrowly beat estimates and raised its sales outlook for the year, but Stryker stock slipped Wednesday on light earnings guidance.

Stryker sees its Relative Strength Rating reach the 80-plus level.

Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts.

With rapidly increasing healthcare demands, numerous technological breakthroughs, and advanced research and development, the medical industry is well-poised for remarkable growth and profitability. As medical companies Danaher (DHR) and Stryker (SYK) gear to report their fourth-quarter earnings tomorrow, let’s determine if these stocks are ideal buys ahead of earnings….

Stryker stock tumbled Friday after sales of its hip and knee replacements came up short, stoking worries of pressure from weight-loss drugs.

The market rally held up, for now, amid a Fed forecast of two more rate hikes. Tesla ended a big win streak. Medical product firms flashed buy signals.

The Health and Safety Authority (HSA) is continuing to investigate to the incident. It is understood that workers were evacuated from the building.

A second fire led to a temporary evacuation of employees following on from a fire last week that left a man on life support